Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001189888 | SCV001357261 | likely benign | Familial hypercholesterolemia | 2018-11-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001453730 | SCV001657429 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-04-12 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800963 | SCV002046561 | likely benign | not provided | 2021-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356858 | SCV002655238 | likely benign | Cardiovascular phenotype | 2019-08-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001800963 | SCV004009848 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | PCSK9: BP4, BP7 |
All of Us Research Program, |
RCV001453730 | SCV004840591 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-05-31 | criteria provided, single submitter | clinical testing | |
GENin |
RCV001189888 | SCV005441497 | likely benign | Familial hypercholesterolemia | 2024-10-22 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |